T1	Participants 15 36	chronic heart failure
T2	Participants 496 655	1457 patients enrolled in the Controlled Rosuvastatin Multinational Trial in HF (CORONA) and 1233 patients enrolled in the GISSI-Heart Failure trial (GISSI-HF)
